These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Apolipoprotein C-II amyloid fibrils assemble via a reversible pathway that includes fibril breaking and rejoining. Binger KJ; Pham CL; Wilson LM; Bailey MF; Lawrence LJ; Schuck P; Howlett GJ J Mol Biol; 2008 Feb; 376(4):1116-29. PubMed ID: 18206908 [TBL] [Abstract][Full Text] [Related]
7. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion. Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616 [TBL] [Abstract][Full Text] [Related]
8. Lysophospholipids induce the nucleation and extension of beta2-microglobulin-related amyloid fibrils at a neutral pH. Ookoshi T; Hasegawa K; Ohhashi Y; Kimura H; Takahashi N; Yoshida H; Miyazaki R; Goto Y; Naiki H Nephrol Dial Transplant; 2008 Oct; 23(10):3247-55. PubMed ID: 18467373 [TBL] [Abstract][Full Text] [Related]
11. Kinetics of fibril formation of bovine kappa-casein indicate a conformational rearrangement as a critical step in the process. Leonil J; Henry G; Jouanneau D; Delage MM; Forge V; Putaux JL J Mol Biol; 2008 Sep; 381(5):1267-80. PubMed ID: 18616951 [TBL] [Abstract][Full Text] [Related]
12. Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils. Fu X; Korenaga T; Fu L; Xing Y; Guo Z; Matsushita T; Hosokawa M; Naiki H; Baba S; Kawata Y; Ikeda S; Ishihara T; Mori M; Higuchi K FEBS Lett; 2004 Apr; 563(1-3):179-84. PubMed ID: 15063745 [TBL] [Abstract][Full Text] [Related]
14. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis. Wilson LM; Mok YF; Binger KJ; Griffin MD; Mertens HD; Lin F; Wade JD; Gooley PR; Howlett GJ J Mol Biol; 2007 Mar; 366(5):1639-51. PubMed ID: 17217959 [TBL] [Abstract][Full Text] [Related]
15. Transthyretin forms amyloid fibrils at physiological pH with ultrasonication. Misumi Y; Ueda M; Fujimori H; Shinriki S; Meng W; Kim J; Saito S; Obayashi K; Uchino M; Ando Y Amyloid; 2008 Dec; 15(4):234-9. PubMed ID: 19065294 [TBL] [Abstract][Full Text] [Related]
16. C-terminal sequence of amyloid-resistant type F apolipoprotein A-II inhibits amyloid fibril formation of apolipoprotein A-II in mice. Sawashita J; Zhang B; Hasegawa K; Mori M; Naiki H; Kametani F; Higuchi K Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E836-45. PubMed ID: 25675489 [TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of lactoferrin aggregation and amyloid formation. Nilsson MR; Dobson CM Biochemistry; 2003 Jan; 42(2):375-82. PubMed ID: 12525164 [TBL] [Abstract][Full Text] [Related]
18. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features. Baskakov IV; Bocharova OV Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746 [TBL] [Abstract][Full Text] [Related]
19. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Hurshman AR; White JT; Powers ET; Kelly JW Biochemistry; 2004 Jun; 43(23):7365-81. PubMed ID: 15182180 [TBL] [Abstract][Full Text] [Related]
20. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. Morozova-Roche LA; Zurdo J; Spencer A; Noppe W; Receveur V; Archer DB; Joniau M; Dobson CM J Struct Biol; 2000 Jun; 130(2-3):339-51. PubMed ID: 10940237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]